Evidence map›Paper›PMID 32175502›Full record

ArticleACS omega2020

Supercritical CO

Sudhir Kumar Sharma, Sumaya Al Hosani, Mona Kalmouni, Anjana Ramdas Nair, Loganathan Palanikumar, Renu Pasricha, Kirsten C Sadler, Mazin Magzoub, Ramesh Jagannathan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. The potential role of miR-155 in the tumorigenesis of cervical cancer.Frontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sudhir Kumar SharmaEngineering Division, New York University, Abu Dhabi, UAE.
Sumaya Al HosaniProgram in Biology, New York University, Abu Dhabi, UAE.
Mona KalmouniProgram in Biology, New York University, Abu Dhabi, UAE.
Anjana Ramdas NairProgram in Biology, New York University, Abu Dhabi, UAE.
Loganathan PalanikumarProgram in Biology, New York University, Abu Dhabi, UAE.
Renu PasrichaCore Technology Platform, New York University, Abu Dhabi, UAE.
Kirsten C SadlerProgram in Biology, New York University, Abu Dhabi, UAE.
Mazin MagzoubProgram in Biology, New York University, Abu Dhabi, UAE.
Ramesh JagannathanEngineering Division, New York University, Abu Dhabi, UAE.
New York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin is a highly toxic material used clinically as a potent chemotherapeutic. While effective against some cancers, toxicity limits widespread use and low solubility confounds delivery. To formulate a better tolerated and more water-soluble form of cisplatin, we designed a rapid expansion of supercritical solutions (RESS) technique with supercritical carbon dioxide (sc-CO

Identifiers

PMID32175502
PMCPMC7066560
OpenAlexW3008689692

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.